These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 31894001)

  • 1. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies and therapeutics].
    Desgranges C
    Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display-derived human antibodies in clinical development and therapy.
    Frenzel A; Schirrmann T; Hust M
    MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?
    Dimitrov DS; Marks JD
    Methods Mol Biol; 2009; 525():1-27, xiii. PubMed ID: 19252861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging trends and therapeutic applications of monoclonal antibodies.
    Mekala JR; Nalluri HP; Reddy PN; S B S; N S SK; G V S D SK; Dhiman R; Chamarthy S; Komaragiri RR; Manyam RR; Dirisala VR
    Gene; 2024 Oct; 925():148607. PubMed ID: 38797505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development trends for human monoclonal antibody therapeutics.
    Nelson AL; Dhimolea E; Reichert JM
    Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances of monoclonal antibodies and analysis of marketed antibody drugs].
    Gu G; Fang M
    Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1431-1447. PubMed ID: 38783807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Antibody Engineering and Selection Strategies.
    Ministro J; Manuel AM; Goncalves J
    Adv Biochem Eng Biotechnol; 2020; 171():55-86. PubMed ID: 31776591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of monoclonal antibodies.
    Berger M; Shankar V; Vafai A
    Am J Med Sci; 2002 Jul; 324(1):14-30. PubMed ID: 12120821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies: A Review.
    Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
    Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Antibodies in Medicine.
    Sharma P; Joshi RV; Pritchard R; Xu K; Eicher MA
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of therapeutic antibodies for the treatment of diseases.
    Wang Z; Wang G; Lu H; Li H; Tang M; Tong A
    Mol Biomed; 2022 Nov; 3(1):35. PubMed ID: 36418786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage Display Technology as a Powerful Platform for Antibody Drug Discovery.
    Nagano K; Tsutsumi Y
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33504115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
    Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
    Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licensed monoclonal antibodies and associated challenges.
    Khan AH; Sadroddiny E
    Hum Antibodies; 2015 Dec; 23(3-4):63-72. PubMed ID: 27472864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive monoclonal antibodies: current and next generation.
    Focosi D; Maggi F; Pistello M; Boggi U; Scatena F
    Clin Microbiol Infect; 2011 Dec; 17(12):1759-68. PubMed ID: 21995285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
    Alfaleh MA; Alsaab HO; Mahmoud AB; Alkayyal AA; Jones ML; Mahler SM; Hashem AM
    Front Immunol; 2020; 11():1986. PubMed ID: 32983137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.